Araba Chintoh
Biographic Data
| ID | 7591040 |
|---|---|
| NAME | Araba Chintoh |
| GIVEN NAMES | Araba |
| FAMILY NAME | Chintoh |
| SIGNATURE | CHINTOH A |
| AFFILIATIONS | Allen Institute for Brain Science |
| ORCID | 0000-0002-7775-5810 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Out of Focus
Embodied dimensions of treatment resistance (TR) are challenging to delineate. • A diffractive methodology can help generate different ways of knowing. • Digital storytelling is a valuable tool to complicate illness narratives. • Lived experiences of TR traverse conventional notions of a unitary self and time. • TR becomes intelligible through intra-actions and entanglements
Treatment resistance in schizophrenia and depression as an interactive kind
Despite ongoing attempts to delineate and name treatment resistance (TR) in psychiatry, the term is increasingly deployed across diagnostic categories. Still, what it is that constitutes TR remains unclear and in flux. Through a meta-narrative review, we construct a sociohistorical map of the concept of TR as it is employed in schizophrenia (TRS) and major depressive disorders (TRD). We track debates about TR, identify underlying assumptions and …
Metabolomic signatures associated with weight gain and psychosis spectrum diagnoses
Psychosis spectrum disorders (PSDs), as well as other severe mental illnesses where psychotic features may be present, like bipolar disorder, are associated with intrinsic metabolic abnormalities. Antipsychotics (APs), the cornerstone of treatment for PSDs, incur additional metabolic adversities including weight gain. Currently, major gaps exist in understanding psychosis illness biomarkers, as well as risk factors and mechanisms for AP-induced w…
No prominent works on this page.
Metabolomic signatures associated with weight gain and psychosis spectrum diagnoses
Psychosis spectrum disorders (PSDs), as well as other severe mental illnesses where psychotic features may be present, like bipolar disorder, are associated with intrinsic metabolic abnormalities. Antipsychotics (APs), the cornerstone of treatment for PSDs, incur additional metabolic adversities including weight gain. Currently, major gaps exist in understanding psychosis illness biomarkers, as well as risk factors and mechanisms for AP-induced w…
Treatment resistance in schizophrenia and depression as an interactive kind
Despite ongoing attempts to delineate and name treatment resistance (TR) in psychiatry, the term is increasingly deployed across diagnostic categories. Still, what it is that constitutes TR remains unclear and in flux. Through a meta-narrative review, we construct a sociohistorical map of the concept of TR as it is employed in schizophrenia (TRS) and major depressive disorders (TRD). We track debates about TR, identify underlying assumptions and …
Out of Focus
Embodied dimensions of treatment resistance (TR) are challenging to delineate. • A diffractive methodology can help generate different ways of knowing. • Digital storytelling is a valuable tool to complicate illness narratives. • Lived experiences of TR traverse conventional notions of a unitary self and time. • TR becomes intelligible through intra-actions and entanglements
Psychiatry (3 works) · Psychology (3 works) · Clinical Psychology (2 works) · Medicine (2 works) · Narrative (2 works) · Philosophy (2 works) · Schizophrenia research and treatment (2 works) · Alcoholism and Thiamine Deficiency (1 work) · Art (1 work) · Biology (1 work)